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Abstract
Antibodies at gastrointestinal mucosal membranes play a vital role in immunological protec-
tion against a range of pathogens, including helminths. Gastrointestinal health is central to
efficient livestock production, and such infections cause significant losses. Fecal samples
were taken from 114 cattle, across three beef farms, with matched blood samples taken
from 22 of those animals. To achieve fecal antibody detection, a novel fecal supernatant
was extracted. Fecal supernatant and serum samples were then analysed, using adapted
enzyme-linked immunosorbent assay protocols, for levels of total immunoglobulin (Ig)A,
IgG, IgM, and Teladorsagia circumcincta-specific IgA, IgG, IgM and IgE (in the absence of
reagents for cattle-specific nematode species). Fecal nematode egg counts were conducted
on all fecal samples. Assays performed successfully and showed that IgA was the predominant
antibody in fecal samples, whereas IgG was predominant in serum. Total IgA in feces and
serum correlated within individuals (0.581, P = 0.005), but other Ig types did not. Results sup-
port the hypothesis that the tested protocols are an effective method for the non-invasive
assessment of cattle immunology. The method could be used as part of animal health assess-
ments, although further work is required to interpret the relationship between results and
levels of infection and immunity.
Introduction
Infection of cattle with parasites, especially gastrointestinal nematodes (GINs), incurs import-
ant economic losses, while options for control are undermined by anthelmintic drug resist-
ance. Targeted selective treatment (TST), whereby drugs are provided only to individuals in
greatest need, has the potential to yield long-term benefits to animal health at individual,
herd and national levels due to its mitigating effect on the selection of drug-resistant pathogens
(van Wyk et al., 2006; Charlier et al., 2014). Central to TST strategies is the need for compre-
hensive animal health assessments, used to select individuals for treatment (Bath and van
Wyk, 2009; Bentounsi et al., 2012; Charlier et al., 2014). This screening process can involve
a range of non-specific health indicators, such as weight gain, body condition and evidence
of diarrhoea, in tandem with more specific indicators of infection such as fecal egg counts
(FECs). A significant drawback of FEC techniques is that egg counts are not necessarily indi-
cative of parasite burden, or of consequent pathology or impact on health. The advancement of
TST requires the development of new, high throughput diagnostics that are able to assess
physiological parameters of animal health, especially in relation to GINs. Fecal antibody detec-
tion (FAD) is a candidate to join this tool kit of techniques, allowing for more detailed and
comprehensive evaluations of animal health, therefore enhancing current TST strategies.
Gastrointestinal health is particularly important for efficient feed conversion within live-
stock production systems and general animal health. The gut wall acts as an interactive barrier
between the external environment and the rest of the animal’s systems, allowing for the pas-
sage of beneficial nutrients into the body. However, the gut wall is also a primary entry point
and barrier for ingested pathogens that have the potential to cause extensive physiological
damage and ultimately reduce nutrient utility and subsequent animal health and performance
(Sykes et al., 1975; Smith et al., 1985; Parkins and Holmes, 1989; Poppi et al., 1990; Coop and
Holmes, 1996; Claerebout and Vercruysse, 2000). A key component in this defence against
pathogens is the immune system and its response at mucosal membranes (Miller, 1987;
Nawa et al., 1994; Onah and Nawa, 2000; Nagler-Anderson, 2001; Sansonetti, 2004) including
immunoglobulins (Ig), which directly combat pathogens and other foreign bodies. Each of the
five Ig isotypes (IgA, IgD, IgE, IgG and IgM) has numerous subtypes that play different roles
and are generally localized to specific systems or tissues.
Heightened antibody levels are often symptomatic of disease challenge and an individual’s
response to that; however, challenge does not necessarily relate to pathology if an animal is
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coping (Newkirk et al., 2005; Dong et al., 2008). Over the course
of an infection, antibody levels vary greatly and are typically char-
acterized by a primary and secondary response; therefore, anti-
body levels at a single time point may not necessarily correlate
with disease burden. Antibody levels are widely measured to indi-
cate exposure, response and tolerance of hosts to GINs and other
pathogens. This is practised most commonly in the dairy industry,
with testing of bulk-tank milk samples used to assess herd health
and inform disease control strategies (Nielsen et al., 2000; Stabel
et al., 2002; Sekiya et al., 2013; Parker et al., 2017). A limitation of
antibody quantification in non-milk-yielding individuals is the
necessity for an invasive sampling procedure. A second limitation
is that different tissues will have a different balance of antibodies
due to their source, such that milk antibody levels are not directly
comparable to serum antibody levels, and neither necessarily
reflect mucosal immunity. There is therefore a need for a non-
invasive method of antibody quantification that is applicable to
all individuals, irrespective of age, gender and other variables.
Furthermore, FAD has the potential to more directly derive infor-
mation regarding gastrointestinal health than equivalent diagnos-
tics on milk or serum.
For the purposes of animal health investigation, enzyme-linked
immunosorbent assays (ELISAs) are typically conducted on
plasma, serum or milk samples. However, a small number of stud-
ies have utilized animal fecal samples collected in the laboratory
(Wedrychowicz et al., 1985) and field (Peters et al., 2004; Watt
et al., 2015). Watt et al. (2015) specifically measured antibodies
of Teladorsagia circumcincta, a GIN. While T. circumcincta is pre-
dominantly a parasite of sheep, there is mounting evidence for the
cross-reactivity of antibodies, produced against antigens of a spe-
cific nematode, to other GIN species (Blanchard and Wescott,
1985; Molina et al., 1999; Ruma et al., 2016). Immunological
results from fecal material are more likely to be representative
of gastrointestinal mucosal membranes than those from other tis-
sues such as plasma, due to the physiologically localized nature of
immunity (Lamm, 1988; Wennerås et al., 1999), therefore provid-
ing novel and complementary information about animal health.
There is the potential for FAD ELISAs to allow for quantitative
assessment of the immunological status of gastrointestinal muco-
sal membranes as a function of general animal health, gut health
or GIN challenge. Fecal material is easily and commonly collected
for the purpose of FECs. The benefits of FAD and the novel infor-
mation it can provide makes it a promising technique for the
future veterinary, agricultural and zoological studies into animal
health.
The primary objective of the research presented here was to
determine the feasibility of a cattle fecal supernatant as a suitable
material for quantitative detection of antibodies using ELISA.
Further, to assess if fecal antibody levels are representative of
those at mucosal membranes: spefically, whether IgA is the
most abundant antibody in both cases. Finally, to assess whether
fecal antibody levels correlate with serum antibody levels and
FEC.
Methods
Sample collection and processing
Sample herds
Fecal samples were taken from cattle at three UK beef farms.
Farm #1 was at Rothamsted Research’s North Wyke Farm
Platform, in Devon, England. The Farm Platform has three non-
organic, pasture-fed beef herds, under typical managed rotation.
Each herd is similar but grazes on different pasture systems. An
initial sampling on 10/11/2016 collected 45 fecal samples and
the second sampling on 07/02/2016 collected 18 fecal samples,
six of which were from animals sampled the first time around.
Both sampling instances occurred during housing when animals
were on a locally produced silage diet.
Farm #2 was a pasture-fed beef farm in Hertfordshire,
England. Animals were mob-grazed, i.e. frequently moved to
new pasture, with movement approximately every 3 days.
Sampling occurred once, on 02/02/2017, during housing, when
30 fecal and 22 blood samples were taken from 30 individuals.
The farm was organic (soil association certified) and no anthel-
mintic treatment had been administered during the monitored
season.
Farm #3 was a pasture-fed beef farm in Angus, Scotland. Cattle
were mob-grazed and moved between fields up to three times per
day. Sampling occurred once, on 07/12/2017, and resulted in the
collection of fecal samples from 30 animals. Animals grazed year-
round with no housing. The farm was organic (soil association
certified) and no anthelmintic treatment had been administered
during the monitored season.
Blood serum
Tail venepuncture was conducted, by a trained and licensed veter-
inarian, from 22 individuals on farm #2, to withdraw blood for
regulated disease testing; sub-samples were taken for FAD.
Blood samples were only collected from animals for which
matched dung samples were available, and blood and fecal sam-
ples were taken on the same day. Samples were drawn, by sterile
syringe, into labelled 10 mL BD Vacutainers® and rested for
>30 min to allow for clotting. Samples were then centrifuged at
2500 rpm/1056 × g (Sorvall SLA-3000 rotor in a Sorvall RC-5B
centrifuge) for 15 min and the supernatant serum withdrawn,
using sterile pipette tips, into 1.5 mL microcentrifuge tubes
(Thermo Scientific™ 3451). Samples were immediately stored at
−20 °C until analysis.
Fecal supernatant
A dung supernatant was obtained by the dilution of fresh cattle
dung with a protease inhibitor, centrifuging and withdrawal of
supernatant.
Fresh dung was collected from individual animals immediately
after deposition, using a clean, single-use polystyrene spoon.
Dung was homogenized by stirring before collection, with care
taken not to mix in foreign matter such as other dung and hay.
Collected samples were transferred to sterile polystyrene screw-
top containers. During sampling, the samples were stored in a
cool box with ice packs, after which they were stored at −20 °C
until being processed.
In order to create the supernatant, dung samples were allowed to
defrost at room temperature (approximately 3 h). Defrosted samples
were thoroughly mixed using sterile inoculating needles (Camlab,
UK). Between 2 and 4 g of dung was then transferred to a sterile bea-
ker and mixed with a protease inhibitor (cOmplete, EDTA-free
Protease Inhibitor Cocktail, Roche, Basel, Switzerland) at a recorded
ratio of between 1:1 and 1:2 (w/v). The resulting mixture was homo-
genized using sterile inoculating needles and then transferred to ster-
ile 10 mL centrifuge tubes (Oak Ridge High-Speed PPCO, Nalgene,
USA) and rested on ice for >10 min, until centrifuging. Samples
were centrifuged at 3–6 °C and 8400 rpm/12 000 × g (Sorvall
SLA-3000 rotor in a Sorvall RC-5B centrifuge, ThermoFisher
Scientific, Waltham, Massachusetts, USA) for 5 min. The super-
natant was then pipetted, using sterile pipette tips, into 1.5 mL
microcentrifuge tubes (Thermo Scientific, USA). Samples were
immediately stored at −20 °C until analysis.
Three negative control protease inhibitor blanks for the super-
natant diluent were created, comprising of 100% protease inhibi-
tor cocktail. Each blank came from a different batch of inhibitor
cocktail and was prepared separately.
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Assay protocol
Seven, bovine-specific ELISAs were conducted. Total IgA, IgG
and IgM ELISAs were conducted using bovine-specific commer-
cial components (Bethyl Laboratories Inc., Montgomery, Texas,
USA) and a reference serum, per the manufacturer’s protocol.
A further three ELISAs were conducted using T. circumcincta
antigen, measuring the responses of bovine-specific IgA, IgG,
IgM and IgE to the antigen. No commercial bovine-specific IgE
components were available, so a fourth assay was completed
using a sheep IgE ELISA. These latter ELISAs were conducted
using the same protocol as for the commercial ELISAs with the
alteration that the commercial capture antibody was replaced
with a T. circumcincta antigen, as per (Watt et al., 2015). No
IgD antibodies were available for inclusion.
Each ELISA was conducted on all 114 fecal supernatant sam-
ples and 22 serum samples. Each of the total Ig plates contained a
10-point dilution series of reference material and two or more
blanks of TBST (Tris‐buffered saline with Tween20 at 0.05%),
representing the sample diluent. Three protease inhibitor blanks
were also included in each assay. The T. circumcincta assays do
not have a reference serum available, so had a known positive
sample included twice, which showed that the assay worked on
that day. The positive control was serum from sheep that had
been trickle infected with T. circumcincta and had confirmed
antigens against L3 T. circumcincta, as per (Watt et al., 2015).
Sample dilution
Supernatant and sera had to be diluted to ensure that optical
densities (ODs) were within the detection limits set by the sig-
moidal curve. Samples were serial diluted and six concentrations
(later narrowed down to three) taken forward for use in assays.
For each assay and material, one dilution was chosen across all
samples as the one to derive results from (see Supplementary
material).
Laboratory procedure
Ninety-six-well plates (Nun-Immuno MicroWell MaxiSorp,
ThermoFisher Scientific) were coated with 50 µL of the matched
rabbit anti-bovine antibody, diluted to 2 µg mL−1 in 0.06 M car-
bonate buffer. For the T. circumcincta assays, the coat was T. cir-
cumcincta L3 somatic antigen at 2 µg mL−1 in 0.06 M carbonate
buffer. Plates were then covered in a cling film, and stored for
1–3 days at 4 °C prior to use. Plates were removed from the
refrigerator and washed 3× in TBST. Meanwhile, samples were
defrosted at room temperature (approximately 1 h) and then ser-
ial diluted in 2 mL deep-well plates. Fifty microlitres of the appro-
priate sample dilutions were pipetted into the relative wells on the
plate. TBST and protease inhibitor-negative controls were then
added. For total antibody assays, the serial dilutions of reference
serum were added, acting as a positive control, but also providing
concentration curves for later interpolation. For T. circumcincta
assays, a known positive sheep sample was used as a plate-positive
control on the four assays. Plates were then covered in a cling film
and incubated for 1 h at 37.5 °C.
Plates were removed from the incubator and washed 5× in
TBST. Fifty microlitres of the appropriate rabbit anti-bovine
HRP-conjugated antibody was added to each plate (excluding
for the T. circumcincta IgE assay). No direct HRP-conjugated
antibody was available for the T. circumcincta IgE assay and
instead 50 µL of mouse anti-ovine IgE (monoclonal IgG1) at
10 µL mL−1 with TBST was added. Teladorsagia circumcincta
IgE plates were then incubated for 1 h at 37.5 °C, washed 5×
with TBST and then 50 µL of goat anti-mouse IgG1-HRP detec-
tion, at 0.125 µg mL−1 with TBST, was added. All plates were then
covered in a cling film and incubated for 1 h at 37.5 °C.
After incubation, plates were washed 5× in TBST. One hundred
microlitres of TMB substrate (KPL, Gaithersburg, Maryland, USA,
SureBlue™ TMB Microwell Peroxidase Substrate – single compo-
nent) was added to each well, plates were then incubated, in dark-
ness, for 5 min at 37.5 °C. Plates were removed from the incubator
and 100 µL of the stop solution, 1.0 M HCl, was added to each well
(the addition of HCL inhibits enzyme activity and changes the wells
from blue to yellow). Plates were immediately read by a plate reader
at 450 nm, providing the OD for each well.
Interpolation and adjustment
For each assay quantifying abundances of a total antibody class,
the 10-point dilution series was graphed as a sigmoidal curve of
OD and antibody concentration. Sample ODs were interpolated
onto this curve to generate an antibody concentration for each
sample. These concentrations were then adjusted to account for
two instances of in vitro sample dilution, which occurred initially
when fecal supernatants were formed and again during serial dilu-
tions of supernatants. This generated the final concentration of
antibody in each fecal sample.
Due to the lack of reference material available for T. circum-
cincta-specific antibody assays, it was not possible to interpolate
the results to generate an exact concentration. Instead, a relative
scale was created, using the positive control, to allow for simple
comparison of samples relative to one another. The value given
to each sample was derived from equation (1). As per total anti-
body class assays, results were then adjusted to account for in vitro
dilution. In the event that negative values were obtained (i.e. if
sample OD was less than TBST OD), values were converted to
zero.
= sample OD− TBST OD
positive control OD− TBST OD . (1)
Equation (1) – Formula used to generate a relative and arbi-
trary scale for T. circumcincta antibody levels.
Validation
Reference material was essential to confirm the validity of assays
and to calculate antibody levels. Total IgA, IgG and IgM reference
material was present on each plate of their matched assay.
Reference material stock concentrations for total IgA, IgG and
IgM were: 0.11, 24 and 1.8 µg µL−1, respectively. Twenty-six dilu-
tions of reference materials were formed using halving serial dilu-
tions. The initial dilution wash 80 µL of reference material with
920 µL of TBST. Seven hundred microlitres of that solution was
then withdrawn and added to 700 µL of TBST and the process
repeated to form a series of up to 26 dilutions, of which 10
were chosen for each assay (see Supplementary material).
Chosen dilutions were based on the past experience of similar
assays, which were then tested to ensure suitability, by visually
assessing if they produced sigmoidal curves. Before experimental
assays were conducted, plates were run with the specified dilu-
tions of reference materials to confirm that the generated curves
were suitable and within the detection limits of the assay and
plate reader, each assay was repeated five times and plates
included two blanks of TBST. As no T. circumcincta antibody ref-
erence material was available, and therefore could not be quanti-
fied, results were measured in relation to other samples. However,
the T. circumcincta-positive controls were available and used to
confirm that the assay worked.
Fecal egg counts
FECs were conducted on all fecal samples used in the ELISA
assays. In addition, each farm had FECs conducted in the grazing
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season leading up to sampling, with FECs conducted on 10 ran-
domly collected samples on each of the four to seven sampling
visits per farm.
FECs were completed in duplicate, using mini-Flotac and
fill-Flotac devices (University of Naples Federico II, Naples,
Italy) (Cringoli et al., 2010; Bosco et al., 2014), in accordance
with manufacturer methods (5.0 g of faces in 45 mL of flotation
solution), giving an analytic sensitivity of five eggs per gram
(epg). A flotation solution of 1.34 g mL−1 zinc sulphate in deio-
nized water was used. Total eggs counted across both wells of
the mini-flotac plate were multiplied by five to determine epg.
Statistical analysis of antibody results
Validations
Assay validity was confirmed using reference material results. For
total IgA, IgG and IgM assays, ODs from the 10-point dilution
curves were plotted and assays considered valid if sigmoidal
curves were produced by the data plots. For T. circumcincta assays
(for which no reference material was available), the assay was
considered valid if the positive controls were significantly higher
than TBST blanks, as determined by a two-sample t-test.
For fecal supernatants to be validated as a suitable medium for
Ig assays, ODs of fecal supernatants, for at least one antibody type,
must be higher than that of blanks. This was determined through
two-sample t-tests individually comparing fecal supernatant anti-
body levels to those of TBST and fecal supernatant-negative
controls.
Antibody levels
One-way analyses of variance (ANOVAs) with Tukey tests were
used to determine if antibody concentrations differed between
fecal and serum samples and if concentrations of different anti-
bodies differed within samples. This was implemented for both
the total antibody assay dataset and for the T. circumcincta dataset
independently. Initial tests were conducted on both serum and
fecal antibody levels combined, to determine differences in anti-
body concentrations and levels between the two materials.
Fecal and serum data were then split and the tests conducted
to identify differences in the abundance of the different antibody
types within those two datasets. Due to a large number of negative
samples, zero value results were removed from T. circumcincta
datasets and ANOVAs repeated.
For both the fecal supernatant and serum datasets, Pearson’s
correlations were performed on all antibody pairings to determine
the correlations between antibody classes and subtypes. Further
correlations were then conducted to compare the levels of the
same antibodies between blood and fecal samples taken from
the same animal on the same day. Bonferroni adjustments were
made to account for multiple comparisons. Further correlations
were also performed on 21 paired serum and fecal supernatants,
derived from the same animal, on the same day. A final set of cor-
relations were performed to determine if any antibody types cor-
related with FEC results (total nematode epg).
Results
Validation of protocol
Assay validation
Ten-point dilution series for each total IgA, IgG and IgM all pro-
duced sigmoidal curves (Fig. 1).
Positive controls for the T. circumcincta assays yielded consist-
ent and significantly higher ODs than the negative controls
(Fig. 2). These differences were confirmed by two-sample t-tests
for each T. circumcincta antibody, IgA (T = 25.29, P < 0.0005),
IgG (T = 16.44, P < 0.0005), IgM (T = 17.79, P < 0.0005) and IgE
(T = 35.39, P < 0.0005).
Fecal supernatant validation
Fecal supernatant OD values were generally greater than those of
TBST and protease inhibitor-negative controls (Fig. 3). The
exceptions were T. circumcincta IgA, which was not significantly
higher than its protease inhibitor control, and T. circumcincta IgE,
which was not significantly higher than either of its blanks.
Antibody levels
IgA was the most abundant antibody isotype in fecal samples,
while IgG was the most abundant antibody isotype in serum
samples.
Total antibody concentrations of positive samples varied
greatly (Fig. 4). A one-way ANOVA, with a post hoc Tukey test,
across all total antibody datasets, found that serum antibody con-
centrations were significantly higher than fecal antibody concen-
trations (F = 162.21, P < 0.0005). A second one-way ANOVA and
Tukey test, comparing just fecal antibody concentrations, found
fecal IgA concentrations to be significantly greater than serum
IgG and IgM, which were not significantly different to one
another according to the Tukey test (F = 50.60, P < 0.0005). A
final one-way ANOVA and Tukey test, solely comparing serum
antibody concentrations, found that serum IgG concentrations
were significantly greater than serum IgA and that both were sig-
nificantly greater than serum IgM (F = 18.97, P < 0.0005).
Fig. 2. Boxplots comparing negative and positive controls for all Teladorsagia circum-
cincta assays, for the purpose of validating the ELISA.
Fig. 1. Sigmoidal curves generated from 10-point dilution series of reference material
for IgA, IgG and IgM assays (total and subtype).
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The variation in T. circumcincta antibody levels was much less
pronounced than for total antibody concentrations. A one-way
ANOVA with a post hoc Tukey test found that T. circumcincta
IgG levels were significantly greater than all other T. circumcincta
antibodies in the combined dataset of feces and serum, all of
which were not significantly different to one another (F =
548.06, P < 0.0005). These trends were still apparent when the
fecal and serum datasets were isolated and analysed independ-
ently (F = 2.11, P = 0.098 and F = 152.46, P < 0.0005, respectively).
However, when only positive samples were included in the
analysis, an ANOVA and Tukey test on fecal samples found
T. circumcincta IgA to be significantly greater than the other
antibodies, which were statistically not different to one another
(F = 4.00, P = 0.008) (Fig. 5).
Fecal nematode egg counts
On farm #1, 29% of animals had GIN eggs in their feces; among
these animals, the mean epg was 17 (S.E. 7.7). On farm #2, 17% of
animals were positive, with a mean epg of 139 (S.E. 82.6). Farm #3
had 27% of animals recorded as positive, of which the mean epg
was nine (S.E. 1.8).
Correlations
Antibody correlations
The majority (14/21) fecal antibody correlations were found to be
significant (Table 1). Of the seven non-significant correlations,
five were for pairings that included T. circumcincta IgE.
Of the 21 correlations conducted, only one serum antibody
pairing (IgM vs T. circumcincta IgM) correlated significantly
(Table 2).
When comparing levels of the same antibody taken from fecal
and serum samples of the same individuals on the same day, the
only significant correlation found was with IgA concentrations
(Table 3).
Antibody vs FEC
FECs correlated negatively with all antibody types; however,
correlations were all <0.1 and non-significant.
Discussion
Assay validity
The experiment achieved its primary objective, to quantify anti-
body levels in cattle feces, and is therefore considered a valid
protocol. Results from reference materials and controls provided
sufficient evidence that the commercial ELISA products worked
effectively, providing a stable foundation from which to assess
the validity of the protocol. Positive controls for the T. circum-
cincta assays also provided evidence that they too worked
effectively.
The greater mean ODs observed from fecal supernatants, com-
pared with the blanks of TBST or protease inhibitor, support the
validity of a fecal supernatant as a suitable material for ELISAs.
This highlights the potential for fecal material to be used in the
immunological assessment of animal health, particularly cattle
and other ruminants.
Interpretation
Across fecal samples, levels of IgA, both total and T. circumcincta
specific, were significantly higher than those of all other anti-
bodies. This result is consistent with the literature, that IgA is
by far the most abundant antibody at mucosal membranes
(Hughes et al., 1981; Lamm, 1988; Macpherson et al., 2008).
This finding supports that fecal antibody levels are indicative of
mucosal membrane antibody levels, as seen in humans (Crabbé
Fig. 3. Unadjusted, ‘raw’ optical densities for fecal supernatant, protease inhibitor-
negative controls and TBST-negative controls, across all assays. Less than symbols
(<) above control columns signify that their ODs are statistically significantly less
than the sample ODs for the same antibody, as determined by a two-sample t-test.
Fig. 4. Boxplots of total antibody concentrations [log (μg/mL +)] measured across all
cattle fecal and serum samples.
Fig. 5. Boxplots of Teladorsagia circumcincta-specific antibody levels (arbitrary units)
measured across all fecal and serum samples. Y-axis is a log scale.
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and Heremans, 1968; Tomasi, 1970; Baklien and Brandtzaeg,
1975; Bjerke et al., 1986). To confirm this, post-mortem intestinal
washes could be utilized to recover mucosal antibodies and other
biomarkers (Negrão-Corrêa et al., 1996) for comparison with
those found in feces from the same individual. During gut transit,
organic material, which later ends up in feces, might accumulate
biomarkers from mucosal membranes, making feces a rich
resource for the assessment of gut health. The most abundant
antibody in serum was IgG, which is also expected given the lit-
erature (Fahey and McKelvey, 1965; Hughes et al., 1981). This
provides additional reassurance that the various assays accurately
and proportionally represent antibody levels in the relevant tissue/
material. Similar relative antibody abundances in feces were also
observed in sheep by Watt et al. (2015).
Only 15% of fecal samples were returned as positive after FEC,
providing an inadequate amount of positive data to determine with
any certainty, if a correlation exists between nematode egg counts
and fecal antibody levels. The negative correlations observed
(although non-significant) are consistent with the observations by
Watt et al. (2015). The lower fecal antibody levels and lack of cor-
relation with FECs may stem from hypobiosis as samples were
taken during late autumn and early winter (Capitini et al., 1990).
Moreover, observed FECs were rather low. A longitudinal study,
tracking seasonal fecal antibody trajectories would clarify this
and potentially provide a more suitable FEC dataset for analysis.
Assays for T. circumcincta-specific antibodies were only able to
provide relative and arbitrary results due to there being no avail-
able reference material. The total antibodies standard curves could
not be used for interpolation of T. circumcincta antibodies as the
relative avidities of both capture antibodies is unknown. To
achieve quantitative concentrations, a reference sample with a
known concentration of the relative T. circumcincta antibodies
would need to be created. This would require the artificial infec-
tion of a host animal (likely sheep), with T. circumcincta, followed
by slaughter and measurement of antibody concentrations in the
blood, which was not a viable option in the current work.
Application
The absence of a correlation between blood and fecal antibody
levels shows that the method is not a replacement or proxy for
measurements of systemic antibody levels. However, results sup-
port the utility of FAD to derive specific information about ani-
mal health that cannot easily be obtained otherwise. This
information may prove to be of greater use and relevance for
the assessment of GIN derived, and other, gut damage, than cir-
culating serum antibodies. Similar recent advances have seen the
development and adoption of salivary antibody tests, for the study
of GIN in sheep (Shaw et al., 2012). The Carla Saliva Test detects
Carla antibodies (Harrison et al., 2003) in sheep saliva; however,
these antibodies are also present in gastrointestinal mucus, mean-
ing that FAD may be a suitable approach for measuring Carla
antibodies. The primary disadvantage of a salivary test, compared
with FAD, is the necessity to perform an invasive procedure on a
restrained animal. Research and development of FAD methodolo-
gies and associated technologies, using advancements on salivary
antibody tests as a template, has the potential to create a highly
practical and informative diagnostic method.
It is evident that FAD has the ability to quantify symptomatic
and important aspects of animal immunology; however, there is
Table 1. Pearson’s correlation results for different antibodies measured within fecal samples
IgA IgG IgM T. IgA T. IgG T. IgM T. IgE
IgA 0.562* 0.700* 0.300* 0.651* 0.514* −0.050
Correlations
IgG <0.0005* 0.453* 0.161 0.345* 0.238 −0.203
IgM <0.0005* >0.0005* 0.485* 0.640* 0.530* −0.180
T. IgA 0.001* 0.085 <0.0005* 0.781* 0.622* 0.079
T. IgG <0.0005* <0.0005* <0.0005* <0.0005* 0.654* 0.011
T. IgM <0.0005* 0.007 <0.0005* <0.0005* <0.0005* 0.364*
T. IgE 0.593 0.028 0.053 0.402 0.905 <0.0005*
P values
The top right half of the chart shows the correlation statistics and the bottom left half shows the P value. Results with an asterisk (*) are statistically significant at an adjusted critical P value
of 0.0024. ‘T.’ refers to Teladorsagia circumcincta. n = 116.
Table 2. Pearson’s correlation results for different antibodies measured within blood samples
IgA IgG IgM T. IgA T. IgG T. IgM T. IgE
IgA 0.487 0.418 0.161 −0.138 0.103 0.359
Correlations
IgG 0.021 0.500 0.530 0.352 0.324 0.141
IgM 0.053 0.018 0.439 0.268 0.669* 0.445
T. IgA 0.473 0.011 0.041 0.235 0.370 0.155
T. IgG 0.541 0.108 0.227 0.291 0.545 −0.110
T. IgM 0.650 0.141 0.001* 0.090 0.009 0.014
T. IgE 0.101 0.131 0.038 0.490 0.625 0.952
P values
The top right half of the chart shows the correlation statistics and the bottom left half shows the P value. Results with an asterisk (*) are statistically significant at an adjusted critical P value
of 0.0024. ‘T.’ refers to Teladorsagia circumcincta. n = 22.
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limited understanding about what precisely fecal antibody levels
indicate, especially in relation to pathogen-driven pathology.
Given the multi-functional role of antibodies, FADs may be
best used as a general marker of animal gut health and disease
challenge, particularly from gastrointestinal pathogens such as
GINs, and applied as part of a TST strategy. Larger scale and
more longitudinal studies are necessary to further understand
how FAD could best be utilized.
Detection of molecules within feces need not be restricted to
antibodies, and there are a range of biomarkers to which the out-
lined protocols might be adapted. Two prime candidate molecules
are the inflammatory markers: lactoferrin and calprotectin, which
are routinely quantified within human medicine, for the diagnosis
of bowel diseases (Røseth et al., 1999; Lundberg et al., 2005;
Gisbert et al., 2009; Lamb and Mansfield, 2011). Furthermore,
gut inflammation can be symptomatic of GIN damage.
Lactoferrin is monitored in milk as part of quality and safety
assurance, therefore bovine assays are commercially available.
Pepsinogen and gastrin ELISAs can be used as veterinary immu-
nodiagnostic tools for GIN infections and are therefore also
strong candidates for fecal detection, given their established utility
as immuno-markers (Berghen et al., 1993; Charlier et al., 2011).
The outlined protocols produce a large amount of fecal super-
natant, providing enough for multiple assays. Once protocols have
been developed, throughput can be extremely high; within this
study, for example, sixteen 96-well plates could be completed
manually within one day. This number could be increased, for
example, with automated pipetting machines. This brings about
the possibility of fecal supernatants being used to provide a wealth
of immunological data, paired with other measures of animal
health, as part of a comprehensive and longitudinal animal health
assessment, driving highly targeted individual interventions to
support efficient and sustainable disease control.
In conclusion, the results presented advance the potential of
animal feces as a resource for veterinary diagnostics. Consistent
positive Ig levels, above background levels, combined with the
range and distribution of results, support the methodology as a
valid immunological tool. Results indicated that fecal antibody
levels are representative of gastrointestinal immunology, due to
the similarity in antibody profiles of fecal material compared
with those observed at mucosal membrane surfaces, with IgA
being the most abundant antibody (Lamm, 1988; Mazanec
et al., 1993; Macpherson et al., 2008). This is also in-keeping
with the passage and processing of material through the gut
and into feces. Therefore, FAD has the potential to provide
novel and unique information about gastrointestinal health and
immunology.
FAD is a new, but promising, capability to assess immuno-
logical aspects of ruminant gut health in a timely and cost-effect-
ive manner. The method is highly ethical as it is non-invasive,
which brings the additional benefit of not requiring trained veter-
inarians or licensing under animal protection legislation. For
more comprehensive interpretation of fecal antibody levels, fur-
ther work needs to be performed to determine the drivers of
fecal antibody concentrations, most notably the role of pathogens.
Successful FAD protocols within this study and by Watt et al.
(2015) suggest that FAD might be more widely applicable to
other mammals, particularly ruminants. Further advancements
in the detection of fecal immuno-markers could, in the future,
become part of a comprehensive tool kit for the assessment of
animal health and development of disease prevention strategies.
Supplementary material. The supplementary material for this article can
be found at https://doi.org/10.1017/S0031182018000902.
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